Industry News

University of Utah to Speed Process of Bringing New Therapeutics to Patients

University of Utah Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center: Nov 18, 2020 10:00 AM The…
Quansys Biosciences Receives FDA Emergency Use Authorization for its SARS-CoV-2 IgG Antibody Test that Provides Exceptional Clinical Performance

Logan, UT, October 28, 2020 – Quansys Biosciences announced today that the U.S. Food and Drug Administration (FDA)…
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal

Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement…
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed with TP-1454 in Patients with Advanced Solid Tumors

CAMBRIDGE, Mass., October 9, 2020 – Sumitomo Dainippon Pharma Oncology, Inc., a developer of novel cancer therapeutics, today…
Pediatric Rare Disease Voucher Program Extended

Congress recently provided a short-term extension until December 11 of the Rare Pediatric Disease Priority Review Voucher program.…
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor

Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical…
Johnson & Johnson Signs Communiqué on Expanded Global Access for COVID-19

Johnson & Johnson recently announced that it’s joined 15 other companies in signing a Communiquie on Expanded Global…
Xenocor Granted Breakthrough Technology Agreement with Premier Inc.

Xenoscope New Disposable Fog-Free Laparoscopic System Made Available to 4,000 Healthcare Facilities in the USA SALT LAKE CITY,…
Mountain Pacific Venture Fund Invests in Laparoscopic Device Company Xenocor

For Immediate Release Xenocor’s single-use laparoscope, Xenoscope, increases access to minimally invasive surgical care Salt Lake City, October…
Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives

Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized…
J&J Enters Phase 3 Trial for COVID-19 Vaccine

BioUtah member Johnson & Johnson (J&J) announced that they’ve started the global phase 3 trial of Janssen’s single-dose…
The Point Kick Off

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning…